Noticias de SCYX_US

Noticias del mercado

Últimas noticias sobre SCYX_US — 42 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: SCYX_US ✕ 42 resultados
31/03/2026 SCYX_US — Stock Titan
Kidney disease drug with Phase 2 study due this year joins SCYNEXIS
31/03/2026 SCYX_US — Stock Titan
SCYNEXIS lands cash to fund rare disease drug work into mid-2029
31/03/2026 SCYX_US — TradingView ES ← EN
Scynexis adquiere el programa activador AMPK de Poxel y paga 8 millones de dólares por adelantado más hasta 188 millones de dólares por hitos
31/03/2026 SCYX_US — Contract Pharma
Poxel Sells Kidney‑Disease Drug Candidate to Scynexis for Up to $196 Million
31/03/2026 SCYX_US — Investing.com
SCYNEXIS acquires SCY-770 for rare kidney disease treatment
31/03/2026 SCYX_US — Investing.com
SCYNEXIS raises $40 million in private placement financing
31/03/2026 SCYX_US — TipRanks
SCYNEXIS Acquires SCY-770, Refocuses on Rare Kidney Disease
31/03/2026 SCYX_US — Stocktwits
Scynexis In Spotlight After Poxel Deal, $40 Million Private Placement – SCYX Stock Climbs 2% Pre-Market
31/03/2026 SCYX_US — TipRanks
SCYNEXIS Raises $40 Million in Strategic Private Placement
31/03/2026 SCYX_US — The Manila Times
SCYNEXIS Announces $40.0 Million Private Placement
31/03/2026 SCYX_US — The Manila Times
SCYNEXIS Completes Transformative Acquisition of PXL-770, an innovative, highly selective, direct AMPK activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
31/03/2026 SCYX_US — Yahoo Finance
Poxel Announces the Sale of PXL770 to Scynexis for a Total Amount of up to $196 Million
31/03/2026 SCYX_US — BioSpace
Poxel Announces the Sale of PXL770 to Scynexis for a Total Amount of up to $196 Million
28/03/2026 SCYX_US — laocai.gov.vn
What makes SCYNEXIS (SCYX) Stock attractive or not | Price at $1.00, Down 0.06% - Fast Rising Picks
28/03/2026 SCYX_US — haiphong.gov.vn
What makes SCYNEXIS (SCYX) Stock attractive or not | Price at $1.00, Down 0.06% - Community Volume Signals
26/03/2026 SCYX_US — Contagion Live
First Participants Dosed in Phase Trial of SCY-247, Building on Oral Formulation Success
22/03/2026 SCYX_US — Stock Titan ES ← EN
Si invirtió $1000 en Scynexis (SCYX)
12/03/2026 SCYX_US — Yahoo Finance
SCYNEXIS, Inc. (SCYX) Announces First Participants Dosed in Phase 1 Trial of SCY-247 Antifungal Therapy
09/03/2026 SCYX_US — Investing.com ES ← EN
Brookline Capital recorta el precio objetivo de las acciones de SCYNEXIS por valoración
04/03/2026 SCYX_US — The Globe and Mail
SCYNEXIS Reports Full Year 2025 Financial Results and Provides Corporate Update

Página 2 de 3

keyboard_arrow_up